isoborneol has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, T; Lai, H; Li, L; Li, X; Su, J; Wong, YS | 1 |
| Chen, J; Chen, T; Li, L; Su, J | 1 |
2 other study(ies) available for isoborneol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Camphanes; Carcinoma, Hepatocellular; Caspases; Cell Proliferation; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Hep G2 Cells; Humans; MAP Kinase Signaling System; Mitochondria; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Tumor Suppressor Protein p53 | 2013 |
Natural borneol enhances bisdemethoxycurcumin-induced cell cycle arrest in the G2/M phase through up-regulation of intracellular ROS in HepG2 cells.
Topics: Absorption, Physiological; Antineoplastic Agents, Phytogenic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Camphanes; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Curcuma; Curcumin; Cyclin B; Diarylheptanoids; Drug Synergism; Food Additives; G2 Phase; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Rhizome; Tumor Suppressor Protein p53 | 2015 |